Cancer researchers find up to one-quarter of lung cancer patients may be ineligible for immunotherapy
A significant proportion of lung cancer patients also have autoimmune disease, which may make them unsuitable for increasingly popular immunotherapy treatments.
More intensive management of high blood pressure, below a commonly recommended blood pressure target, significantly reduces rates of cardiovascular disease, and lowers risk of death in a group of adults 50 years and older with high blood pressure.
Dr. James de Lemos, Medical Director for the CTM's Dallas Heart Study, is one of three UTSW faculty members elected as new members of the American Society for Clinical Investigation.
Miguel Vazquez, M.D., Medical Director of Kidney Transplantation and Professor of Internal Medicine, has received one of three new research awards that will address the growing proportion of the U.S. population with multiple chronic medical conditions.
During his 42-year career, Robert Haley, M.D., has unraveled many medical mysteries and become a widely respected epidemiologist.
Using clinical research resources available at UT Southwestern, a team of investigators has demonstrated a significant role for fatty acid synthesis in the development of nonalcoholic fatty liver disease.
Scott M. Grundy, M.D., Ph.D., was #1 in total citations in the field of metabolic syndrome in November 2011, as ranked by Essential Science Indicators SM from Thomson Reuters.
Sponsor-Investigators more likely to receive FDA warnings
Robert Toto, M.D., Associate Dean of Clinical and Translational Research, recently gave a presentation entitled
Kimberly Kho, M.D., Assistant Professor of Obstetrics and Gynecology and former Clinical Scholar with the Center for Translational Medicine, was quoted in a New York Times article about a JAMA paper she recently co-authored.